1Mazza M, Pollice R, Gaspari V, et al. Efficacy of adjunctive donepezil for cognitive impairments in patients with schizophrenia[J]. Clin Ter,2005,156(5) :203-209.
2Bora E, Veznedaroglu B,Kayahan B. The effect of galantamine added to clozapine on cognition of five patients with schizophrenia[J]. Clin Neuropharmacol,2005,28(3) : 139-141.
3Buchanan RW,Conley RR, Dickinson D, et al. Galantamine for the treatment of cognitive impairments in people with schizophrenia[J]. Am J Psychiatry,2008,165(1) :82-89.
4Lee BJ, Lee JG, Kim YH. A 12-week, double-blind, placebocontrolled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic sehizophrenia[J]. J Psychopharmacol, 2007,21 (4) : 421-427.
5Akhondzadeh S, Gerami M, Noroozian M, et al. A 12-week, double blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32 (8):1810-1815.
6Keefe RS,Malhotra AK,Meltzer HY,et al. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12 week, randomized, double blind, placebo-controlled trial [J]. Neuropsyehopharmacology, 2008,33 ( 6 ) : 1217-1228.
7Rosse RB, Deutsch SI. Adjuvant galantamine administration improves negative symptoms in a patient with treatment- refractory schizophrenia [J]. Clin Neuropharmacol, 2002, 25 (5) :272- 275.
8Conley RR, Boggs DL, Kelly DL, et al. The effects of galantamine on psychopathology in chronic stable schizophrenia[J]. Clin Neuropharmacol,2009,32(2) :69-74.
9Wang D,Noda Y,Zhou Y,et al. Synergistic effect of combined treatment with risperidone and galantamine on pbencyclidine- induced impairment of latent visuospatial learning and memory: Role of nAChR activation-dependent increase of dopamine D1 receptor-mediated neurotransmission [J]. Neuropharmacology, 2007,53 (3) :379-389.
10Risch SC, Horner MD, McGurk SR, et al. Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder[J]. Int J Neuropsychopharmacol, 2006, 9 (5) : 603- 605.
3Borison R L. The role of cognition in the risk-benefit and safety analysis of antipsychotic medication[J]. Acta Psychiatry Scand, 1996,94(9):5-11.
4Mazza M, Pollice R, Gaspari V, et al. Efficacy of adjunctive done- pezil for cognitive impairments in patients with schiz0phrenia[J]. Clin Ter,2005,156(5):203-209.
5Anisman H, Merali Z, H Ayley S. Neurot ransmit t er,peptide and cyt okine process es in relat ion t o depress ive dis order:comor- bidit y b etw een depression an d neurodegenerat ivedisorders[J]. P rog N eur obiol, 2008, 8(5): 71-74.
6Stanley M. Cholinergic receptors binding in the Frontal Cortex of Suicide Victims[J], AmJ Psychiatry, 1986,30(2):343-349.
7Raskin J, Wiltse C, Siegal A, et al. Efficacy of duloxetine on cog- nition,depression,and pain in elderly patients with major depres- sivedisorder:an 8-week,double-blind,placebo-controlled trial [J].American Journal of Psychiatry,2007,164(6):900-909.
8Bora Emre,Veznedaro?lu Baybars,Kayahan Bülent.The effect of galantamine added to clozapine on cognition of five patients with schizophrenia. Clinical Neurophysiology . 2005
9Bong-Ju Lee,Jung-Goo Lee,Young-Hoon Kim.A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia. Journal of Psychopharmacology . 2007
10Shahin Akhondzadeh,Maryam Gerami,Maryam Noroozian,Narges Karamghadiri,Aboulfazl Ghoreishi,Seyed-Hesameddin Abbasi,Sams-Ali Rezazadeh.??A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia(J)Progress in Neuropsychopharmacology & Biological Psychiatry . 2008 (8)
